四川科伦博泰生物医药股份有限公司（“科伦博泰生物”，股票代码：06990）于2026年6月4日披露，截至2026年5月31日的股份变动月报表。本次报告期内，公司注册股本为人民币233,185,969元，维持不变。
报告显示，截至2026年5月末，科伦博泰生物H股已发行股份（不含库存股）为170,984,257股，内资股为62,201,712股，二者均与上月结存数相同；本月未发生新增发行、购回或注销，也不存在新增库存股份。公司确认其对公众持股量的比例已符合香港联合交易所有限公司相关规定。
另据公告，科伦博泰生物于2025年12月通过股份激励计划，计划授予366名承授人合计435,064份限制性股票单位，未来通过发行新H股完成。本月度并未有实际新股发行或库存股转让发生。公司进一步确认，月内所有股份相关事务均已履行香港联交所《上市规则》及法律法规要求。本次公告由公司联席公司秘书周泽剑签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.